Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target DLL3 (clone SC1G6Z.5L6Z). We employs the Retrovirus (EF1α-BFP-LEF/TCF-EcoRI) vector components and the SynExpress system of the Exons RNA Editing/Positive feedback for a robust and sustained response against cancers.
Host
Humanized
Target
DLL3
Clone
SC1G6Z.5L6Z
Species Reactivity
Mouse
Cell Source
Modified CD8+ T cells
Sensor Gene
BFP
Promoter
EF1α
Effector Gene
LEF/TCF
Insertion Sites
EcoRI
Gene Modification
RNA Editing
Modification Domain
Exons
Carrier Type
Retrovirus
Transformation Accuracy
0.95
Cell Culture
Adherent Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.